{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:44:06Z","timestamp":1791290646376,"version":"4.3.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100016286","name":"Urmia University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["painmanagementnursing.org","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pain Management Nursing"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.pmn.2024.07.001","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T21:37:49Z","timestamp":1723585069000},"page":"e31-e35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of the Efficacy of Propranolol Versus Valsartan in the Prevention of Migraine: A Randomized Controlled Trial"],"prefix":"10.1016","volume":"26","author":[{"given":"Arash","family":"Mosarrezaii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danial","family":"Tahazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Soleimantabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Panahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmn.2024.07.001_bib0001","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/head.14153","article-title":"The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice","volume":"61","author":"Ailani","year":"2021","journal-title":"Headache: The Journal of Head and Face Pain"},{"key":"10.1016\/j.pmn.2024.07.001_bib0002","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/head.12550","article-title":"Acute migraine treatment in adults","volume":"55","author":"Becker","year":"2015","journal-title":"Headache: The Journal of Head and Face Pain"},{"key":"10.1016\/j.pmn.2024.07.001_bib0003","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","article-title":"Migraine: Epidemiology, burden, and comorbidity","volume":"37","author":"Burch","year":"2019","journal-title":"Neurologic Clinics"},{"key":"10.1016\/j.pmn.2024.07.001_bib0004","doi-asserted-by":"crossref","DOI":"10.1177\/03331024231183166","article-title":"The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis","volume":"43","author":"Carcel","year":"2023","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pmn.2024.07.001_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11940-019-0556-3","article-title":"Beta-blockers for migraine prevention: A review article","volume":"21","author":"Danesh","year":"2019","journal-title":"Current Treatment Options in Neurology"},{"key":"10.1016\/j.pmn.2024.07.001_bib0006","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/0333102419828967","article-title":"Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults","volume":"39","author":"Diener","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pmn.2024.07.001_bib0007","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s10072-015-2217-y","article-title":"Angiotensin II receptor blockers: A new possible treatment for chronic migraine?","volume":"36","author":"Disco","year":"2015","journal-title":"Neurological Sciences"},{"key":"10.1016\/j.pmn.2024.07.001_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11916-019-0823-8","article-title":"Efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the preventative treatment of episodic migraine in adults","volume":"23","author":"Dorosch","year":"2019","journal-title":"Current Pain and Headache Reports"},{"key":"10.1016\/j.pmn.2024.07.001_bib0009","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0002-9343(02)01100-2","article-title":"Efficacy of angiotensin II receptor antagonists in preventing headache: A systematic overview and meta-analysis","volume":"112","author":"Etminan","year":"2002","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.pmn.2024.07.001_bib0010","first-page":"S30","article-title":"Prophylactic treatment of migraine","volume":"50","author":"G\u00fcrsoy","year":"2013","journal-title":"Noro Psikiyatr Ars"},{"key":"10.1016\/j.pmn.2024.07.001_bib0011","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10072-017-2854-4","article-title":"Treatment with telmisartan, a long-acting angiotensin II receptor blocker, prevents migraine attacks in Japanese non-responders to lomerizine","volume":"38","author":"Ikeda","year":"2017","journal-title":"Neurological Sciences"},{"key":"10.1016\/j.pmn.2024.07.001_bib0012","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1007\/s00415-018-9066-6","article-title":"Migraine prophylactic management in neurology and primary care (2006\u20132015)","volume":"265","author":"Jackson","year":"2018","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.pmn.2024.07.001_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212785","article-title":"Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis","volume":"14","author":"Jackson","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.pmn.2024.07.001_bib0014","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s10194-023-01594-1","article-title":"The comparative effectiveness of migraine preventive drugs: A systematic review and network meta-analysis","volume":"24","author":"Lampl","year":"2023","journal-title":"The Journal of Headache and Pain"},{"key":"10.1016\/j.pmn.2024.07.001_bib0015","first-page":"652","article-title":"Clinical Inquiries. How effectively do ACE inhibitors and ARBs prevent migraines?","volume":"67","author":"Morris","year":"2018","journal-title":"J Fam Pract"},{"key":"10.1016\/j.pmn.2024.07.001_bib0016","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s13311-017-0592-1","article-title":"Migraine treatment: Current acute medications and their potential mechanisms of action","volume":"15","author":"Ong","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pmn.2024.07.001_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10194-019-1010-3","article-title":"Optimising migraine treatment: From drug-drug interactions to personalized medicine","volume":"20","author":"Pomes","year":"2019","journal-title":"The Journal of Headache and Pain"},{"key":"10.1016\/j.pmn.2024.07.001_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11940-019-0559-0","article-title":"Other preventive anti-migraine treatments: ACE inhibitors, ARBs, calcium channel blockers, serotonin antagonists, and NMDA receptor antagonists","volume":"21","author":"Rau","year":"2019","journal-title":"Current Treatment Options in Neurology"},{"key":"10.1016\/j.pmn.2024.07.001_bib0019","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.phrs.2017.06.017","article-title":"Beneficial effects of angiotensin II receptor blockers in brain disorders","volume":"125","author":"Saavedra","year":"2017","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pmn.2024.07.001_bib0020","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2174\/0929866527666200129160136","article-title":"Renin-angiotensin-aldosterone system and migraine: A systematic review of human studies","volume":"27","author":"Sassi","year":"2020","journal-title":"Protein and Peptide Letters"},{"key":"10.1016\/j.pmn.2024.07.001_bib0021","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/jwh.2018.7274","article-title":"Sex and gender differences in migraine\u2014Evaluating knowledge gaps","volume":"27","author":"Schroeder","year":"2018","journal-title":"Journal of Women's Health"},{"key":"10.1016\/j.pmn.2024.07.001_bib0022","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13311-018-0621-8","article-title":"Current prophylactic medications for migraine and their potential mechanisms of action","volume":"15","author":"Sprenger","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pmn.2024.07.001_bib0023","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41582-022-00763-1","article-title":"Global epidemiology of migraine and its implications for public health and health policy","volume":"19","author":"Steiner","year":"2023","journal-title":"Nature Reviews Neurology"},{"key":"10.1016\/j.pmn.2024.07.001_bib0024","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3959(00)00305-5","article-title":"Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers","volume":"88","author":"Stewart","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.pmn.2024.07.001_bib0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/0333102413515348","article-title":"A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study","volume":"34","author":"Stovner","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pmn.2024.07.001_bib0026","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.289.1.65","article-title":"Prophylactic treatment of migraine with an angiotensin II Receptor Blocker: A randomized controlled trial","volume":"289","author":"Tronvik","year":"2003","journal-title":"JAMA"}],"container-title":["Pain Management Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1524904224002017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1524904224002017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T19:58:32Z","timestamp":1740254312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1524904224002017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1524904224002017"],"URL":"https:\/\/doi.org\/10.1016\/j.pmn.2024.07.001","relation":{},"ISSN":["1524-9042"],"issn-type":[{"value":"1524-9042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the Efficacy of Propranolol Versus Valsartan in the Prevention of Migraine: A Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Pain Management Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmn.2024.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Pain Management Nursing. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}